Searching for a "week by week" Mounjaro guide usually means wanting to know one thing: what is actually normal, and when? This guide outlines a realistic timeline for the first six months of Mounjaro (tirzepatide) treatment, including when side effects are commonly reported, when appetite changes may become noticeable, and the review points that form part of UK prescribing practice.
Everyone responds differently to Mounjaro, so this guide cannot predict exactly what will happen for you. It is also not a substitute for the advice from your prescriber. However, it can give you a useful idea of what to expect, rather than simply saying that "everyone is different" without providing any practical information.
Treatment is overseen by EverydayMeds' UK registered prescribing team following a clinical assessment to determine whether Mounjaro is suitable for you.
Key things to know
- Treatment starts at 2.5mg. This starting dose is intended to help your body adjust to treatment rather than being the usual maintenance dose.
- Gastrointestinal side effects, such as nausea, are commonly reported during the first few weeks and after dose increases. They may become less noticeable as your body adjusts, although this varies between people.
- Appetite and fullness changes may become noticeable within the first few weeks, but the timing and extent of these changes vary from person to person.
- The NHS Better Health programme encourages sustainable weight loss through healthier eating, increased physical activity, improved sleep and long term lifestyle changes, recognising that progress varies from person to person.
- Dose changes are a clinical decision for your prescriber based on your response and tolerance. You should not change your dose yourself.
Week 1 2: Starting Treatment
Mounjaro treatment begins at a 2.5mg starting dose, regardless of your eventual maintenance dose. This is the licensed starting dose and is used to help your body adjust to treatment gradually.
During the first couple of weeks, some people experience gastrointestinal symptoms such as nausea, diarrhoea, reduced appetite or abdominal discomfort. Fatigue can also occur. These are among the side effects reported during Mounjaro treatment, although not everyone experiences them and their severity can vary.
Some people may notice changes in appetite within the first few days, while others may not notice much difference initially. Following the dietary advice provided by your prescriber and choosing smaller meals may help some people manage gastrointestinal symptoms during this period. Staying hydrated is also important, particularly if you experience vomiting or diarrhoea.
Weight loss can also vary considerably during the first few weeks. Some people may see a small change, while others may notice little or no change initially. Early changes should not be used to predict how much weight you will lose over the longer term.
Weeks 3 4: Early Adaptation
By weeks 3 and 4, some people find that early gastrointestinal side effects have started to settle as their body adjusts to treatment. Others may continue to experience symptoms, particularly around an injection or if their dose has recently changed.
This can also be a period when changes in appetite become more noticeable. You may find that you feel fuller sooner, naturally eat smaller portions, or have less interest in snacking. However, these effects vary, and not everyone experiences them at the same point.
Some people also report thinking about food less often before seeing a noticeable change in their weight. This can be a useful reminder that changes in appetite and eating patterns may happen before changes on the scales become obvious.
You will also be settling into your weekly injection routine during this stage. If side effects remain troublesome, become more severe, or are affecting your ability to eat and drink normally, speak with your prescriber rather than assuming that you simply need to push through them.
Month 2: Dose Review and Establishing Patterns
By the second month, you may have become more familiar with the injection routine and how your body responds to Mounjaro. Some early side effects may have settled, although gastrointestinal symptoms can still occur, particularly after a dose increase.
Your prescriber will assess how you are responding to treatment. After the initial 2.5mg dose for four weeks, the next dose is commonly 5mg if your prescriber considers an increase appropriate. Further dose increases may be considered at intervals of at least four weeks, depending on your response and tolerance. There is no need to increase the dose simply because a certain number of weeks have passed.
This is also a useful time to look at the bigger picture. Consider how your appetite, eating habits, physical activity, side effects and weight are changing rather than focusing only on the number on the scales. If something does not feel right or you are struggling with side effects, raise it with your prescriber at your next review.
Months 3 6: Ongoing Treatment and the NICE Review Point
During months 3 to 6, you may start to become more familiar with how Mounjaro affects your appetite, fullness and eating patterns. Some people see steady weight loss during this period, while others experience a slower or less predictable response. In clinical trials, average weight loss was around 8% of starting body weight by approximately week 12, although individual results varied.
One important detail that many week by week guides miss is the NICE review point. Current NICE guidance (TA1026) recommends reviewing treatment at around six months. Treatment may be continued when clinically meaningful weight loss has been achieved, with NICE using at least 5% of starting body weight as the relevant benchmark. This is not a pass or fail test. It is a way for your prescriber to assess whether treatment is providing enough benefit to justify continuing it.
Clinical trials have reported substantial average weight loss over longer treatment periods, with average losses approaching 20% of starting body weight at 72 weeks at some doses. However, these are study averages and do not predict how much weight any individual person will lose.
Mounjaro may be used as part of a longer term weight management plan. Some studies have found that weight can return after treatment is stopped, particularly when lifestyle changes are not maintained. If you are considering stopping treatment, discuss this with your prescriber rather than stopping or changing your dose on your own.
What to Monitor Throughout Treatment
Changes in appetite and feelings of fullness are expected effects of Mounjaro, but sudden or significant changes in your eating pattern are worth discussing with your prescriber. Persistent or worsening nausea, vomiting, diarrhoea or other gastrointestinal symptoms should also be reviewed, particularly if they make it difficult to eat or drink normally.
Seek urgent medical attention if you develop severe or persistent abdominal pain, particularly if it is accompanied by vomiting. Although uncommon, pancreatitis has been reported with tirzepatide and other medicines in this class. Your healthcare team can help you understand whether symptoms are part of the usual adjustment period or need further assessment.
Setting Realistic Expectations
Mounjaro is not a quick fix or a standalone solution. It is used alongside a reduced calorie diet and increased physical activity as part of a wider weight management plan. How quickly you respond can vary considerably from person to person.
It can be tempting to compare your progress with week by week accounts online, but someone else's experience may not reflect what happens for you. A slower rate of weight loss does not necessarily mean that treatment is not working.
Long term weight management also involves sustainable lifestyle habits. A balanced diet, regular meals and adequate protein can help support your nutritional needs while you are losing weight. Regular physical activity is also encouraged. UK guidance generally recommends that adults aim for at least 150 minutes of moderate intensity activity each week, where appropriate for their health and fitness level.
You may also find it useful to keep track of changes in your weight, appetite, eating habits and side effects. This can give you and your prescriber a clearer picture of how you are responding and whether your treatment plan needs reviewing.
Getting Started at EverydayMeds
Mounjaro is available at EverydayMeds following an online clinical assessment, where the UK registered prescribing team reviews your suitability, including your medical history. If prescribed, Mounjaro is taken once a week, at any time of day, with or without meals, according to the instructions provided with your prescription.
As a prescription only medicine, Mounjaro is supplied following a clinical assessment and prescriber approval. The standard price for a single 2.5mg pen, providing four weekly doses, is £174.99. Current promotional pricing, if available, is shown at checkout, as offers can change.
Medical Disclaimer
This page provides general information about what to expect during Mounjaro treatment. It is not a substitute for personalised advice from a healthcare professional or your prescriber. Individual responses to treatment can vary significantly.
Seek urgent medical attention if you develop severe or persistent abdominal pain, particularly if it is accompanied by vomiting. Any changes to your dose should be made only following advice from your prescriber. If you are concerned about a missed dose, check the instructions provided with your medicine or contact your prescriber rather than adjusting your treatment yourself.
